BVF as of Dec. 31, 2022
Portfolio Holdings for BVF
BVF holds 78 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 9.6 | $228M | 22M | 10.50 | |
| Axsome Therapeutics (AXSM) | 5.7 | $135M | 1.8M | 77.13 | |
| Repare Therapeutics Ord (RPTX) | 5.1 | $122M | 8.3M | 14.71 | |
| Kymera Therapeutics (KYMR) | 4.9 | $117M | 4.7M | 24.96 | |
| Gh Research Ordinary Shares (GHRS) | 3.8 | $90M | 9.3M | 9.67 | |
| 4d Molecular Therapeutics In (FDMT) | 3.8 | $89M | 4.0M | 22.21 | |
| Cullinan Oncology (CGEM) | 3.3 | $79M | 7.5M | 10.55 | |
| Revolution Medicines (RVMD) | 3.3 | $78M | 3.3M | 23.82 | |
| Point Biopharma Global | 2.8 | $67M | 9.2M | 7.29 | |
| Xoma Corp Del Com New (XOMA) | 2.8 | $67M | 3.6M | 18.40 | |
| Relay Therapeutics (RLAY) | 2.4 | $58M | 3.9M | 14.94 | |
| Cti Biopharma | 2.2 | $53M | 8.8M | 6.01 | |
| Aclaris Therapeutics (ACRS) | 2.2 | $52M | 3.3M | 15.75 | |
| Xenon Pharmaceuticals (XENE) | 2.1 | $50M | 1.3M | 39.43 | |
| Crinetics Pharmaceuticals In (CRNX) | 2.1 | $50M | 2.7M | 18.30 | |
| Arcus Biosciences Incorporated (RCUS) | 2.0 | $48M | 2.3M | 20.68 | |
| Kura Oncology (KURA) | 2.0 | $47M | 3.8M | 12.41 | |
| Zymeworks Del (ZYME) | 1.9 | $46M | 5.9M | 7.86 | |
| Merus N V (MRUS) | 1.9 | $46M | 3.0M | 15.47 | |
| Immunovant (IMVT) | 1.9 | $46M | 2.6M | 17.75 | |
| Ionis Pharmaceuticals (IONS) | 1.8 | $42M | 1.1M | 37.77 | |
| Allakos | 1.8 | $42M | 5.0M | 8.42 | |
| Replimune Group (REPL) | 1.7 | $41M | 1.5M | 27.20 | |
| Ideaya Biosciences (IDYA) | 1.7 | $40M | 2.2M | 18.17 | |
| Syndax Pharmaceuticals (SNDX) | 1.6 | $37M | 1.5M | 25.45 | |
| Miragen Therapeutics (VRDN) | 1.5 | $36M | 1.2M | 29.21 | |
| Iteos Therapeutics | 1.5 | $35M | 1.8M | 19.53 | |
| Lexicon Pharmaceuticals Com New (LXRX) | 1.3 | $31M | 16M | 1.91 | |
| Glycomimetics | 1.2 | $29M | 9.5M | 3.03 | |
| Rain Therapeutics | 1.2 | $28M | 3.5M | 8.00 | |
| Sutro Biopharma (STRO) | 1.1 | $27M | 3.3M | 8.08 | |
| Silence Therapeutics Ads (SLN) | 1.0 | $23M | 1.5M | 15.25 | |
| Vigil Neuroscience (VIGL) | 1.0 | $23M | 1.8M | 12.50 | |
| Essa Pharma Com New (EPIX) | 0.9 | $22M | 8.7M | 2.52 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.9 | $21M | 6.9M | 3.10 | |
| Concert Pharmaceuticals I equity | 0.9 | $21M | 3.6M | 5.84 | |
| Annexon (ANNX) | 0.8 | $20M | 3.8M | 5.17 | |
| Janux Therapeutics (JANX) | 0.8 | $19M | 1.5M | 13.17 | |
| Tyra Biosciences (TYRA) | 0.8 | $19M | 2.5M | 7.60 | |
| Third Harmonic Bio (THRD) | 0.8 | $19M | 4.4M | 4.30 | |
| Olema Pharmaceuticals (OLMA) | 0.8 | $19M | 7.6M | 2.45 | |
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 0.7 | $16M | 1.5M | 10.52 | |
| Ac Immune Sa SHS (ACIU) | 0.6 | $15M | 7.4M | 2.04 | |
| An2 Therapeutics (ANTX) | 0.6 | $15M | 1.6M | 9.53 | |
| Calliditas Therapeutics Ab Sponsered Ads | 0.6 | $13M | 750k | 17.53 | |
| Ovid Therapeutics (OVID) | 0.5 | $13M | 6.9M | 1.86 | |
| Verve Therapeutics (VERV) | 0.5 | $13M | 650k | 19.35 | |
| Cogent Biosciences (COGT) | 0.5 | $11M | 985k | 11.56 | |
| Cytomx Therapeutics (CTMX) | 0.4 | $11M | 6.6M | 1.60 | |
| Alpine Immune Sciences | 0.4 | $8.3M | 1.1M | 7.35 | |
| Verastem | 0.3 | $7.7M | 19M | 0.40 | |
| Nls Pharmaceutics SHS | 0.3 | $7.4M | 5.7M | 1.29 | |
| Aadi Bioscience (WHWK) | 0.3 | $7.2M | 562k | 12.83 | |
| Ikena Oncology (IKNA) | 0.3 | $6.7M | 2.5M | 2.66 | |
| Aravive | 0.3 | $6.3M | 4.8M | 1.32 | |
| Eledon Pharmaceuticals (ELDN) | 0.2 | $5.4M | 2.3M | 2.32 | |
| Pieris Pharmaceuticals | 0.2 | $5.3M | 5.1M | 1.04 | |
| Viracta Therapeutics (VIRX) | 0.2 | $5.3M | 3.6M | 1.46 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.2 | $5.2M | 6.9M | 0.76 | |
| Galapagos Nv Spon Adr (GLPG) | 0.2 | $4.4M | 100k | 44.38 | |
| Hillevax | 0.2 | $4.2M | 249k | 16.73 | |
| Pyxis Oncology Common Stock (PYXS) | 0.2 | $3.9M | 2.9M | 1.34 | |
| Infinity Pharmaceuticals (INFIQ) | 0.1 | $3.5M | 6.4M | 0.56 | |
| Inventiva Sa Ads (IVA) | 0.1 | $3.0M | 686k | 4.43 | |
| Molecular Partners Ads (MOLN) | 0.1 | $2.9M | 443k | 6.48 | |
| Elevation Oncology (ELEV) | 0.1 | $2.2M | 2.3M | 0.95 | |
| Molecular Templates | 0.1 | $1.6M | 5.0M | 0.33 | |
| Immunic (IMUX) | 0.1 | $1.6M | 1.1M | 1.40 | |
| Selecta Biosciences | 0.1 | $1.6M | 1.4M | 1.13 | |
| Calithera Biosciences Com New (CALA) | 0.1 | $1.5M | 465k | 3.26 | |
| X4 Pharmaceuticals | 0.1 | $1.3M | 1.3M | 0.99 | |
| Corvus Pharmaceuticals (CRVS) | 0.0 | $1.2M | 1.4M | 0.85 | |
| Galmed Pharmaceuticals SHS | 0.0 | $870k | 1.7M | 0.50 | |
| Angion Biomedica Corp | 0.0 | $870k | 1.1M | 0.81 | |
| Aileron Therapeutics Com New (RNTX) | 0.0 | $561k | 237k | 2.37 | |
| Generation Bio | 0.0 | $404k | 103k | 3.93 | |
| Rezolute Com New (RZLT) | 0.0 | $395k | 191k | 2.07 | |
| Bionomics Ads | 0.0 | $373k | 81k | 4.61 |
